Images List Premium Download Classic

Weight Loss

Weight Loss-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Compositions and methods for managing weight
Unigen, Inc.
April 12, 2018 - N°20180099019

The present disclosure provides diels-alder adducts of chalcone and prenylphenyl moieties capable of modulating the activity of cannabinoid receptors, and to oligomers of flavan-3-ol capable of modulating fat absorption and storage. Such diels-alder adducts of chalcone and prenylphenyl moieties or oligomers of flavan-3-ol can optionally be used in combination with other weight management agents, such as anorectic agents, ...
Resin composition suitable for rigid-flex board and use thereof
Elite Material Co., Ltd.
March 29, 2018 - N°20180086910

The disclosure relates to a resin composition, comprising an epoxy resin, a high molecular weight polyetheramine and an amine-terminated acrylonitrile rubber. Various products can be made from the resin composition, such as prepregs, laminates, printed circuit boards or rigid-flex boards, in which one, multiple or all of the following properties can be met: low resin flow, low dust weight loss, ...
Safe sleeve gastrectomy and intestinal switch
March 22, 2018 - N°20180078397

A safe sleeve gastrectomy and intestinal switch reduces gastric volume and calorie intake as a weight loss treatment. The safe sleeve gastrectomy and intestinal switch utilizes a safety pocket to increase safety and guide division of the stomach. An instrument tunnel is created to facilitate division of the stomach into a pouch and a sectioned portion. In this manner, over ...
Weight Loss Patent Pack
Download + patent application PDFs
Weight Loss Patent Applications
Download + Weight Loss-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Weight Loss-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Injection composition comprising hyaluronidase for removal of topical fat
March 15, 2018 - N°20180071372

The present invention relates to an injection composition comprising hyaluronidase for topical fat reduction. More particularly, the present invention relates to an injection composition comprising 300 iu to 600 iu of hyaluronidase and a local anesthetic, an antihistamine, a lipolysis stimulator and a collagen production stimulator. The present invention promotes the reduction of topical fat tissue, thereby improving obesity and helping weight ...
Clinical predictors of weight loss
The General Hospital Corporation D/b/a Massachuset
March 08, 2018 - N°20180066315

Methods and compositions are generally provided for treating metabolic disorders, e. G., obesity. One aspect discloses methods and compositions for obtaining a biological sample from the subject, evaluating the sample for the presence or absence of a genetic indicator, wherein the genetic indicator is selected from a single nucleotide polymorphism and a level of gene expression, and performing a first ...
Methods of treating an overweight subject
Vanderbilt University
March 01, 2018 - N°20180055811

The invention generally relates in part to methods of effecting weight loss and/or improving glucose tolerance in a patient in need thereof, comprising administering a metap2 inhibitor.
Weight Loss Patent Pack
Download + patent application PDFs
Weight Loss Patent Applications
Download + Weight Loss-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Weight Loss-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
The micrbe transformant for weight loss and lipid reduction, the method for constructing the transformant, ...
Nanjing Sinogen Biotech & Pharmaceutical Inc.
February 22, 2018 - N°20180051303

It discloses a transformant for weight loss and lipid reduction, which is obtained by recombining and substituting human oxyntomodulin gene into thymidylate synthase gene of l. Lactis genome. Wherein the recombinant substitution is homologous recombination by artificially synthesizing gene sequences, making the sequence flanking the human oxyntomodulin gene derived from the homologous sequences of thymidylate synthase gene in the l. ...
Composition and use of lactobacillus fermentum gmnl-296 to produce composition for improving symptoms of clostridium ...
Genmont Biotech Inc.
February 22, 2018 - N°20180050072

A composition of lactobacillus fermentum gmnl-296 and a use of lactobacillus fermentum gmnl-296 for producing a composition to improve the infection symptoms of clostridium difficile are provided. The lactobacillus fermentum gmnl-296 is to promote the expression of anti-inflammatory cytokine il-10 and treg cell related transcription factors, so that the infection symptoms of weight loss and intestinal abnormalities are improved.
C16:1n7-palmitoleate and derivatives thereof for treating obesity, promoting weight loss, and supporting weight ...
Tersus Life Sciences, Llc
February 15, 2018 - N°20180042882

The present technology provides methods for treating obesity, promoting weight loss, and supporting weight management in a subject in need thereof. The methods include administering to the subject an effective amount of a composition comprising one or more of c16:1n7-palmitoleate, derivatives thereof, or pharmaceutically acceptable salts thereof.
Biomarkers for predicting degree of weight loss
Nestec S.a.
February 08, 2018 - N°20180038869

A method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject, said method comprising determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the biomarkers are selected from fructosamine and factor vii.
Resin composition and article molded therefrom
Mitsubishi Chemical Corporation
February 01, 2018 - N°20180030240

The present invention relates to: a resin composition comprising a polyacetal resin (a), a salt (b) consisting of a carboxylic acid and an alkaline-earth metal, and a rubber-containing graft polymer (c); and a molded article formed by molding the resin composition. The resin composition and the molded article of the present invention are characterized in that the thermal decomposition associated ...
Compositions and methods for treating obesity and hyperphagia
Mhs Care-innovation Llc
February 01, 2018 - N°20180028618

The present disclosure is directed to the treatment of diseases or conditions characterized by the buildup of fatty tissue, or hyperphagia, such as prader-willi syndrome, obesity, metabolic syndrome, type ii diabetes, etc. A composition containing a monoclonal antibody directed against gastric inhibitory polypeptide is administered. This results in a reduced rate of weight gain, weight loss, and/or reduction in ...
Compositions comprising beta-hydroxybutyric acid and salt, and methods of using the same
Savind, Inc.
January 25, 2018 - N°20180021274

β-hydroxybutyric acid in combination with β-hydroxybutyrate salts are useful to induce ketosis, achieving blood ketone levels of (0. 5-6. 0 mmol/l), with or without dietary restriction, and without inducing harmfully high mineral loads in the blood. The combination of β-hydroxybutyric acid and salt results in substantial improvements in metabolic biomarkers related to insulin resistance, diabetes, ...
Weight Loss Patent Pack
Download + patent application PDFs
Weight Loss Patent Applications
Download + Weight Loss-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Weight Loss-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Stimulation of appetite and treatment of anorexia in dogs and cats
Kindred Biosciences, Inc.
January 25, 2018 - N°20180021251

Pharmaceutical formulations and methods useful for the treatment of anorexia and the stimulation of appetite and weight gain, and the management of weight loss in dogs and cats.
Biomarkers for predicting weight loss and weight maintenance
Nestec S.a.
January 18, 2018 - N°20180016636

A method for assessing the predisposition of a subject to weight loss attainable by applying one or more dietary interventions to a subject and/or the predisposition of a subject to maintenance of weight loss following one or more dietary interventions which method comprises determining the nucleotide of the subject at one or more polymorphic positions selected from: (i) position 101 ...
Methods of treating an overweight or obese subject
Zafgen, Inc.
January 18, 2018 - N°20180016249

The disclosure herein generally relates to methods of treating an overweight or obese condition, and overweight- or obesity-related conditions. In one embodiment, the disclosure provides a method of treating an overweight or obese condition involving administering to the subject in need thereof, an amount of a pharmaceutical composition including a metap-2 inhibitory compound, or a salt, ester, or prodrug thereof, ...
Flexible and collapsible weighted hula hoop
January 11, 2018 - N°20180008854

A flexible hula hoop is made of soft, non-abrasive, flexible, stretchy and collapsible material that is filled with liquid weight before use. This flexible hula hoop can have different amounts of liquid weight for the purpose of different levels of exercise. The hula hoop of this invention uses movement with the body of the user to create momentum for the ...
Compositions and methods for treating metabolic disorders
Elcelyx Therapeutics, Inc.
January 11, 2018 - N°20180008561

Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and/or inducing weight loss in patients in need thereof, particularly in individuals having a contraindication for treatment with biguanide compounds, are provided comprising administering delayed release formulations of such biguanide compounds, including metformin, targeted to the small intestine.
Circovirus sequences associated with piglet weight loss disease (pwd)
Zoetis Services Llc
January 04, 2018 - N°20180000927

The genome sequences and the nucleotide sequences coding for the pwd circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells and animals transformed by the vectors are provided. Methods for detecting the nucleic acids or polypeptides, and kits for diagnosing infection by a pwd circovirus, also are provided. Method for selecting compounds capable ...
Compositions of fatostatin based heterocyclic compounds and uses thereof
Fgh Biotech, Inc.
January 04, 2018 - N°20180000801

The present invention relates to compounds, pharmaceutical compositions and formulations that have a structure (i). The compounds comprise a heterocyclic ring where w, x, y, and z generally and independently are s, n or c with the proviso that at least 2 of these positions in the ring are other than carbon. A pyridine or a substituted pyridine a ring and ...
Systems and methods for enabling a patient to achieve a weight loss objective using an ...
Elira, Inc.
January 04, 2018 - N°20180000347

The disclosed wearable device modulates a patient's gastric emptying time and/or gastric retention time. The wearable device includes a microprocessor, electrical stimulator and at least one electrode configured to deliver electrical stimulation to the epidermis, through a range of 0. 1 mm to 10 mm or a range of 0. 1 mm to 20 mm of the dermis, of a t2 dermatome to a t12 ...
Loading